Skip to main content

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.

Publication ,  Journal Article
Strouse, C; Juckett, M; Logan, BR; Estrada-Merly, N; Peterson, A; Preussler, JM; Truong, TH; Troy, JD; Khera, N; Wood, WA; Rangarajan, HG ...
Published in: JCO Oncol Pract
October 2, 2025

PURPOSE: Public reporting of health care outcomes can have unintended effects such as inappropriate risk aversion in patient selection. METHODS: The center-specific survival analysis annually assigns all hematopoietic cell transplantation (HCT) centers in the United States a +1, -1, or 0 score for observed outcomes that are above, below, or within a center-specific predicted range of outcome. For each index year (2012-2016), centers receiving a -1 score after 0 scores in the preceding 2 years were compared with contemporaneous centers with as-predicted outcomes (0 score). Changes in the patient population characteristics in the 3 years before versus the 3 years after the index years were compared between the newly below-expected centers (NBCs) and the controls. A multivariate model adjusted for baseline patient population characteristics and center volume. RESULTS: No differences in patient selection behavior were identified when comparing the NBCs with the controls across eight key patient population characteristics. For the statistically modeled (predicted) 1-year overall survival (OS), reflecting a holistic measure of centers' patient population risk, we observed no statistically significant difference in change (-0.23% [95% CI, -1.4 to 0.9]; P = .70). The observed OS increased in both NBCs and controls by 0.9% and 4.5%, respectively, without statistically significant difference in change. CONCLUSION: Centers receiving a -1 score were not observed to deviate significantly from patient selection trends in the HCT field. These findings suggest that public reporting of HCT outcomes in the United States does not result in unintended bias against HCT for high-risk patients.

Duke Scholars

Published In

JCO Oncol Pract

DOI

EISSN

2688-1535

Publication Date

October 2, 2025

Start / End Page

OP2500115

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strouse, C., Juckett, M., Logan, B. R., Estrada-Merly, N., Peterson, A., Preussler, J. M., … Saber, W. (2025). Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. JCO Oncol Pract, OP2500115. https://doi.org/10.1200/OP-25-00115
Strouse, Christopher, Mark Juckett, Brent R. Logan, Noel Estrada-Merly, Andrew Peterson, Jaime M. Preussler, Tony H. Truong, et al. “Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.JCO Oncol Pract, October 2, 2025, OP2500115. https://doi.org/10.1200/OP-25-00115.
Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, et al. Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. JCO Oncol Pract. 2025 Oct 2;OP2500115.
Strouse, Christopher, et al. “Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.JCO Oncol Pract, Oct. 2025, p. OP2500115. Pubmed, doi:10.1200/OP-25-00115.
Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, Truong TH, Troy JD, Khera N, Wood WA, Rangarajan HG, Akard LP, Bhatt NS, Sharma A, Rizzo JD, Saber W. Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. JCO Oncol Pract. 2025 Oct 2;OP2500115.

Published In

JCO Oncol Pract

DOI

EISSN

2688-1535

Publication Date

October 2, 2025

Start / End Page

OP2500115

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis